Richter Transformation in the Era of Targeted Therapies - Drs Sameer Parikh & Jean-Nicolas Champagne

42 Visioni

  • Grazie! Condividilo con i tuoi amici!

    Non hai gradito questo video. Grazie per il feedback!

admin
Published
Outcomes for patients with Richter transformation remain poor even with the introduction of targeted therapies. There is a significant unmet need for new, more effective treatment strategies for patients with Richter transformation.

Dr. Jean-Nicolas Champagne from BC Cancer Vancouver and colleagues presented the results at the American Society for Hematology (ASH) Annual Meeting in 2024.

Read the full article on CLL Society's website at: https://cllsociety.org/2025/08/richter-transfomation-in-the-era-of-targeted-therapies/
__________________________________________________________________________________________
CLL Society Website: https://cllsociety.org/
Facebook: https://www.facebook.com/CLLsociety
Twitter: https://twitter.com/CllSociety
LinkedIn: https://www.linkedin.com/company/cll-society/
Categoria
Oncology
Commenta per primo questo video.

Prossimo